Although this was a case report about severe adverse reactions caused by HER2-targeted CAR-T cell therapy for colon cancer, effectively avoiding damage to normal lung tissue is still a problem that needs to be discussed and solved, as HER2-targeted CAR-T is widely used in breast cancer treatment. The gene discussed is ERBB2; the disease is colonic neoplasm.